BRPI0507333A - composição antiparasìtica - Google Patents

composição antiparasìtica

Info

Publication number
BRPI0507333A
BRPI0507333A BRPI0507333-2A BRPI0507333A BRPI0507333A BR PI0507333 A BRPI0507333 A BR PI0507333A BR PI0507333 A BRPI0507333 A BR PI0507333A BR PI0507333 A BRPI0507333 A BR PI0507333A
Authority
BR
Brazil
Prior art keywords
antiparasitically
composition
effective amount
closantel
acceptable carrier
Prior art date
Application number
BRPI0507333-2A
Other languages
English (en)
Inventor
Robert Bruce Albright
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0507333A publication Critical patent/BRPI0507333A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSIçãO ANTIPARASìTICA Proporciona-se uma composição antiparasítica aperfeiçoada que compreende uma quantidade antiparasiticamente efetiva de um sal de amina orgânica de closantel opcionalmente um lactona macrocíclica e um sistema de solvente não irritante que consiste essencialmente de um álcool e um derivado de glicol. Proporciona-se igualmente um método para obtenção de níveis aumentados de closantel no sangue de um animal homeotérmico e um método para proteção aumentada do dito animal contra infecção parasítica.
BRPI0507333-2A 2004-02-02 2005-01-28 composição antiparasìtica BRPI0507333A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54116204P 2004-02-02 2004-02-02
PCT/US2005/003413 WO2005074912A2 (en) 2004-02-02 2005-01-28 Antiparasitic composition containing an organic amine salt of closantel

Publications (1)

Publication Number Publication Date
BRPI0507333A true BRPI0507333A (pt) 2007-07-03

Family

ID=34837467

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507333-2A BRPI0507333A (pt) 2004-02-02 2005-01-28 composição antiparasìtica

Country Status (11)

Country Link
US (1) US7666444B2 (pt)
EP (2) EP2065042A3 (pt)
AT (1) ATE425751T1 (pt)
AU (1) AU2005210660A1 (pt)
BR (1) BRPI0507333A (pt)
CA (1) CA2553039A1 (pt)
DE (1) DE602005013360D1 (pt)
ES (1) ES2323137T3 (pt)
MX (1) MXPA06008751A (pt)
NZ (1) NZ548689A (pt)
WO (1) WO2005074912A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1824474A1 (en) * 2004-12-10 2007-08-29 Bayer HealthCare AG Anthelmintic composition
WO2009070687A1 (en) * 2007-11-26 2009-06-04 Merial Limited Solvent systems for pour-on formulations for combating parasites
AU2013201461B2 (en) * 2007-11-26 2015-10-29 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
EP2416663A2 (en) 2009-03-18 2012-02-15 Martin Benedict George Donnelly Parasiticidal formulation
GB201021836D0 (en) * 2010-12-21 2011-02-02 Norbrook Lab Ltd Topical Composition
JP2017529393A (ja) 2014-09-12 2017-10-05 アンティバイオティクス エーピーエスＡｎｔｉｂｉｏｔｘ Ａｐｓ ハロゲン化サリチルアニリドの抗菌用途
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
UY37137A (es) 2016-02-24 2017-09-29 Merial Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN110279657B (zh) * 2019-07-29 2021-07-27 河南官渡生物工程有限公司 一种氯氰碘柳胺钠注射液及其制备方法
SI3815677T1 (sl) 2019-10-30 2023-12-29 Krka, D.D., Novo Mesto Stabilni veterinarski sestavek, ki obsega moksidektin in imidakloprid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005218A (en) * 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
DE69432985D1 (de) 1993-06-15 2003-09-04 Australian Nat University Acto Synergistische anthelmintische zusammensetzungen gegen fasciola hepatica und andere fascola spezien
NZ248486A (en) 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
AUPQ441699A0 (en) * 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
AUPQ875700A0 (en) 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
CN1375287A (zh) 2001-03-16 2002-10-23 王玉万 含氯氰碘柳胺或其钠盐的兽用混悬注射剂
AU2003215011A1 (en) 2002-02-08 2003-09-02 Mcneil-Ppc, Inc. Topical ivermectin composition
GB2386067A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
FR2839614B1 (fr) 2002-05-14 2004-08-13 Virbac Sa Nouvelles compositions orales huileuses antiparasitaires
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
AU2002952597A0 (en) 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
AU2003284802A1 (en) 2002-11-27 2004-06-18 Eco Animal Health Ltd An injection of animal remedy including closantel or closantel sodium
CA2521268C (en) 2003-04-04 2012-10-16 Merial Ltd. Topical anthelmintic veterinary formulations

Also Published As

Publication number Publication date
ATE425751T1 (de) 2009-04-15
US20050197302A1 (en) 2005-09-08
DE602005013360D1 (de) 2009-04-30
NZ548689A (en) 2010-06-25
WO2005074912A3 (en) 2006-04-20
US7666444B2 (en) 2010-02-23
CA2553039A1 (en) 2005-08-18
WO2005074912A2 (en) 2005-08-18
EP2065042A2 (en) 2009-06-03
EP2065042A3 (en) 2009-07-22
EP1713466B1 (en) 2009-03-18
ES2323137T3 (es) 2009-07-07
AU2005210660A1 (en) 2005-08-18
MXPA06008751A (es) 2007-01-19
EP1713466A2 (en) 2006-10-25

Similar Documents

Publication Publication Date Title
AR057914A1 (es) Compuestos organicos de azufre y su uso
TNSN08409A1 (en) Organic compounds
EP1950219A4 (en) NEW DIHYDROPSEUDOERYTHROMYCIN DERIVATIVES
EP2213662A4 (en) AZAINDENOFLUORENDION DERIVATIVE, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC LUMINESCENT DEVICE
EP2107060A4 (en) PESTICIDES
EA200701121A1 (ru) Потенциаторы рецепторов глутамата
GT200500240A (es) Nuevos herbicidas
CR8831A (es) Compuestos y metodos para el tratamiento de dislipidemia
EP2502908A4 (en) AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT THEREWITH
ATE486879T1 (de) Organische elektrolumineszenzvorrichtung
FR2885453B1 (fr) Dispositifs d'emission de lumiere organique
NO20076347L (no) Nye regimer for orale monofasiske befruktningshindrene midler
EP1993992A4 (en) TETRAPHENYL NAPHTHALIN DERIVATIVES AND ORGANIC LIGHT-EMITTING DIODE WHERE THEY ARE USED
ATE425751T1 (de) Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel
EP1883643A4 (en) Fluorinated organic silicate coating material
NO20071835L (no) Semisynteseprosess for fremstillingen av 10-deacetyl-N-debenzoyl-paklitaxel.
DE602004016127D1 (de) Antagonisten der opioidrezeptoren
ECSP077130A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos
ATE537822T1 (de) Antidepressivum
EP1844172A4 (en) POWDER COMBINATION ON IRON BASE
EP1715728A4 (en) ORGANIC ELECTROLUMINESCENCE ELEMENT
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
IN2014DN04588A (pt)
ATE425948T1 (de) Substituierte hydroxyacetophenonderivative
DK1516626T3 (da) Teicoplanin-sammensætning med forbedret antibiotisk aktivitet

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A, 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.